New concepts of biobanks--strategic chance for uro-oncology (Q37770784)

22 August 2017

1 reference

title

New concepts of biobanks--strategic chance for uro-oncology (English)

1 reference

22 August 2017

0 references

Manuel M Morente

1 reference

22 August 2017

Peter J Goebell

1 reference

22 August 2017

publication date

1 July 2010

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

page(s)

449-457

1 reference

DNA banking for epidemiologic studies: a review of current practices

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The Icelandic database--do modern times need modern sagas?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

7 January 2021

UK Biobank: bank on it.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Health impacts of long-term exposure to disinfection by-products in drinking water in Europe: HIWATE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Tumour banking: the Spanish design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Biobanking: old activity or young discipline?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Trends in ethical and legal frameworks for the use of human biobanks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Biobanking for interdisciplinary clinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Molecular markers for bladder cancer: the road to a multimarker approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Biological markers in the diagnosis of recurrent bladder cancer: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Almost all articles on cancer prognostic markers report statistically significant results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

REporting recommendations for tumor MARKer prognostic studies (REMARK).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Sample size considerations for the evaluation of prognostic factors in survival analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

What do we mean by validating a prognostic model?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Statistical aspects of prognostic factor studies in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Breast cancer prognostic factors: evaluation guidelines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Prognostic factors: guidelines for investigation design and state of the art analytical methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The First and Second International Workshops on Diagnostic and Prognostic Markers in Bladder Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The International Bladder Cancer Bank: proposal for a new study concept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Guidelines for development of diagnostic markers in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Using Laboratory Information Management Systems as central part of a proteomics data workflow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

ms_lims, a simple yet powerful open source laboratory information management system for MS-driven proteomics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

iLAP: a workflow-driven software for experimental protocol development, data acquisition and analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The Hawaiian Algal Database: a laboratory LIMS and online resource for biodiversity data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Technical Considerations in Remote LIMS Access via the World Wide Web.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Human biospecimen research: experimental protocol and quality control tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Biobanking for better healthcare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Collection, Storage, Retrieval and Distribution of Biological Materials for Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The need for independent scientific peer review of Biobank UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

7 January 2021

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

An informatics model for tissue banks--lessons learned from the Cooperative Prostate Cancer Tissue Resource

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

[German Association for Bladder Cancer Research]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Establishment of a European Network for Urine and Kidney Proteomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

OECI TuBaFrost tumor biobanking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Effects of Ischemia on Gene Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Gene expression analysis by real-time reverse transcription polymerase chain reaction: influence of tissue handling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Design and implementation of a high-throughput biological sample processing facility using modern manufacturing principles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Designing an automated blood fractionation system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Designing and implementing a large-scale automated -80 degrees C archive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Design and implementation of a large-scale liquid nitrogen archive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

The UK Biobank sample handling and storage validation studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Standard operating procedure for the collection of fresh frozen tissue samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Biorepository standards and protocols for collecting, processing, and storing human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Tumour banks: well-guarded treasures in the interest of patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.03.012

10.1016/J.UROLONC.2010.03.012

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference